IP Library Granted Patent US 9,822,183
Granted Patent B2
US 9,822,183 · App. 15/158,510 · Granted Nov 21, 2017

CA6 antigen-specific cytotoxic conjugate and methods of using the same

Inventors: Gillian Payne (Waban, MA); Philip Chun (Malden, MA); Daniel J. Tavares (Natick, MA)
Assignee: SANOFI
C07K16/3092A61K31/537A61K47/486A61K47/48384A61K47/48407A61K47/48569A61K47/48584A61K47/48638A61K47/48669C07K14/4727C07K14/4748C07K16/303C07K16/3015C07K16/3069C07K16/464A61K39/39558A61K2039/505C07K2317/14C07K2317/24C07K2317/56C07K2317/565C07K2317/567C07K2317/73C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,822,183
App. No.
15/158,510
Granted
Nov 21, 2017
Kind
B2
Abstract

Cytotoxic conjugates comprising a cell binding agent and a cytotoxic agent, therapeutic compositions comprising the conjugate, methods for using the conjugates in the inhibition of cell growth and the treatment of disease, and a kit comprising the cytotoxic conjugate are disclosed are all embodiments of the invention. In particular, the cell binding agent is a monoclonal antibody, and epitope-binding fragments thereof, that recognizes and binds the CA6 glycotope. The present invention is also directed to humanized or resurfaced versions of DS6, an anti-CA6 murine monoclonal antibody, and epitope-binding fragments thereof.

Claims (20)

1. A polynucleotide comprising a nucleotide sequence encoding the variable heavy chain of SEQ ID NO:11.

2. A polynucleotide comprising a nucleotide sequence encoding the variable heavy chain of SEQ ID NO:10.

3. A polynucleotide comprising a nucleotide sequence encoding the variable light chain of SEQ ID NO:8.

4. A vector comprising the polynucleotide of claim 1 .

5. A vector comprising the polynucleotide of claim 2 .

6. A vector comprising the polynucleotide of claim 3 .

7. A vector comprising the polynucleotide of claim 1 and a polynucleotide comprising a nucleotide sequence encoding the variable light chain of SEQ ID NO:8.

8. A host cell comprising the polynucleotide of claim 1 .

9. A host cell comprising the polynucleotide of claim 2 .

10. A host cell comprising the polynucleotide of claim 3 .

11. A host cell comprising the polynucleotide of claim 1 and a polynucleotide comprising a nucleotide sequence encoding the variable light chain of SEQ ID NO:8.

12. A host cell comprising the vector of claim 4 .

13. A host cell comprising the vector of claim 5 .

14. A host cell comprising the vector of claim 6 .

15. A host cell comprising the vector of claim 7 .

16. A host cell comprising the vector of claim 5 and a vector comprising a polynucleotide comprising a nucleotide sequence encoding the variable light chain of SEQ ID NO:8.

17. The host cell of claim 11 , wherein the host cell is a CHO cell.

18. The host cell of claim 15 , wherein the host cell is a CHO cell.

19. The host cell of claim 16 , wherein the host cell is a CHO cell.

20. A vector comprising the polynucleotide of claim 2 and a polynucleotide comprising a nucleotide sequence encoding the variable light chain of SEQ ID NO:8.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 13, 2017
From: IMMUNOGEN, INC.
To: SANOFI
Reel/Frame 043860/0371 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2016
From: PAYNE, GILLIAN; TAVARES, DANIEL J.
To: IMMUNOGEN, INC.
Reel/Frame 040092/0643 →
CHANGE OF ADDRESS Recorded Oct 21, 2016
From: IMMUNOGEN, INC.
To: IMMUNOGEN, INC.
Reel/Frame 040459/0565 →
Continuity (5)
Division 12912107 · Oct 26, 2010
Division 11213046 · Aug 29, 2005
Continuation In Part 10895135 · Jul 21, 2004
Provisional Application 60488447 · Jul 21, 2003
Related Publication 20160355605A1 · Dec 8, 2016